IN-VITRO ACTIVITY OF BIAPENEM AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA

被引:26
|
作者
MALANOSKI, GJ
COLLINS, L
WENNERSTEN, C
MOELLERING, RC
ELIOPOULOS, GM
机构
[1] NEW ENGLAND DEACONESS HOSP,DEPT MED,BOSTON,MA 02215
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1128/AAC.37.9.2009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activity of biapenem, a new carbapenem previously designated 1,627, was compared with those of imipenem and several other antimicrobial agents against 771 clinical bacterial isolates. Against gram-positive organisms, biapenem was found to be approximately as active as imipenem, inhibiting 90% of isolates of most species at concentrations within one dilution of the MIC of imipenem for 90% of the isolates. Against gram-negative organisms and Bacteroides fragilis, biapenem was at least as active as and often more active than imipenem, with MICs for 90% of the isolates two- to eightfold lower than those of imipenem.
引用
收藏
页码:2009 / 2016
页数:8
相关论文
共 50 条
  • [1] In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates
    Bonfiglio, G
    Maccarone, G
    Mezzatesta, ML
    Privitera, A
    Carciotto, V
    Santagati, M
    Stefani, S
    Nicoletti, G
    [J]. CHEMOTHERAPY, 1997, 43 (06) : 393 - 399
  • [2] Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina
    Lopez, H
    Stepanik, D
    Vilches, V
    Scarano, S
    Sarachian, B
    Mikaelian, G
    Finlay, J
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (04) : 187 - 192
  • [3] In vitro Activity of Tigecycline Against Clinical Isolates of Gram-Positive and Gram-Negative Bacteria Displaying Different Resistance Phenotypes
    Franiczek, Roman
    Dolna, Izabela
    Dworniczek, Ewa
    Krzyzanowska, Barbara
    Seniuk, Alicja
    Piatkowska, Elzbieta
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 17 (05): : 545 - 551
  • [4] Comparative In Vitro Activity of Trovafloxacin Against Gram-Positive and Gram-Negative Clinical Isolates from Argentina
    Adriana Sucari
    D. Stepanik
    J. M. Casellas
    G. Tomé
    L. Clara
    M. Marín
    A. Rossi
    M. Galas
    J. Smayevsky
    L. Dufranc
    H. Lorenzo
    L. de Vedia
    H. López
    [J]. Drugs, 1999, 58 : 195 - 199
  • [5] Comparative in vitro activity of trovafloxacin against Gram-positive and Gram-negative clinical isolates from Argentina
    Sucari, A
    Stepanik, D
    Casellas, JM
    Tomé, G
    Clara, L
    Marín, M
    Rossi, A
    Galas, M
    Smayevsky, J
    Dufranc, L
    Lorenzo, H
    de Vedia, L
    López, H
    [J]. DRUGS, 1999, 58 (Suppl 2) : 195 - 199
  • [6] Pharmacodynamic activity of levofloxacin in an in vitro model against gram-positive and gram-negative bacteria
    Wiedemann, B
    Pfeil, E
    [J]. DRUGS, 1999, 58 (Suppl 2) : 417 - 419
  • [7] Pharmacodynamic Activity of Levofloxacin in an In Vitro Model Against Gram-Positive and Gram-Negative Bacteria
    B. Wiedemann
    E. Pfeil
    [J]. Drugs, 1999, 58 : 417 - 419
  • [8] Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates
    Li, Z. X.
    Liu, Y. N.
    Wang, R.
    Li, A. M.
    [J]. CLINICA TERAPEUTICA, 2015, 166 (06): : E374 - E380
  • [9] INVITRO ACTIVITY OF TICARCILLIN WITH AND WITHOUT CLAVULANIC ACID AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA
    PULVERER, G
    PETERS, G
    KUNSTMANN, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 : 1 - 5
  • [10] INVITRO ACTIVITY OF LOMEFLOXACIN AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA
    ALDRIDGE, KE
    HENDERBERG, A
    SANDERS, CV
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S935 - S935